The Core Model
A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care
- Publisher's listprice EUR 86.95
-
36 062 Ft (34 345 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 3 606 Ft off)
- Discounted price 32 456 Ft (30 911 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
36 062 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 5 June 2019
- ISBN 9780128142936
- Binding Paperback
- No. of pages174 pages
- Size 228x152 mm
- Weight 270 g
- Language English 0
Categories
Long description:
The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care develops the innovative core model, an organizational research and design paradigm and economic theory that proposes a collaborative approach to resolving global health issues and improving the productivity of drug development. The model proposes that scientific collaboration does not occur in an unstructured manner, but actually takes place within a highly structured order where knowledge is transferred, integrated and finally translated into commercial products. An understanding of this model will help solve the global pharmaceutical industryï¿1⁄2s productivity problems and address important global health care and economic issues.
This book is useful to researchers, advanced students, regulators, and management in pharmaceutical industries, as well as healthcare professionals, those working in health economics, and those interested in scientific innovation processes.
MoreTable of Contents:
"
Part I1. Introduction: the remarkable success story of the development of bortezomib2. Lessons from the development of bortezomib: the Core Model
Part II3. The ""Coreï¿1⁄2: when innovation meets leadership 4. ""The Bridgeï¿1⁄2: collaboration is the best catalyst to success5. ""The Peripheryï¿1⁄2: the efficient use of underused societal resources
Part III6. Biopharmaceutical intellectual property, financial interests, and the Core Model7. Global health care crisis, the pharmaceutical industry, and the Core Model8. The Core Model, innovation, economic growth, development, and policy-making
Part IV9. Conclusion: the Core Model: a novel economic theory10. Epilogue: the Core Model and other industries
" More
